đź“‹ FDA Reference
philips veriflex
Philips Medical Systems
Summary: The Philips VeriFlex is a medical device used for embolization procedures, primarily by interventional radiologists. It is designed to occlude blood vessels in various clinical scenarios.
FDA Clearance Information
Pathway
510K
Number
K902849 ↗
Decision Date
August 3, 1990
Product Code
IYE
Device Class
Class 2
Evidence
419 studies
The Philips VeriFlex was cleared through the FDA 510(k) pathway on August 3, 1990. Manufactured by Philips Medical Systems, it is classified as a Class 2 device under product code IYE.
What It Is
The Philips VeriFlex is a liquid embolization agent used to occlude blood vessels in medical procedures. It works by being injected into the target vessel, where it solidifies to block blood flow. This device is essential in procedures requiring precise vascular occlusion, such as treating arteriovenous malformations or controlling bleeding.
Clinical Applications
Commonly used in interventional radiology, the Philips VeriFlex is employed in procedures like embolization of tumors, treatment of vascular malformations, and controlling hemorrhages. It is particularly useful in settings where minimally invasive techniques are preferred, such as in oncology and trauma care, and is suitable for a wide range of patient populations requiring vascular occlusion.
Indications for Use
The FDA indications for the Philips VeriFlex involve its use in embolization procedures. Clinically, this means it is used to block blood vessels in conditions like arteriovenous malformations, tumors, or uncontrolled bleeding.
Practical Considerations
The Philips VeriFlex is available in various viscosities to suit different clinical needs. It is compatible with standard microcatheters used in embolization procedures. Clinicians should be aware of the specific technique required for safe and effective delivery of the embolic agent.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips VeriFlex used for?
Philips VeriFlex is used for embolization procedures to occlude blood vessels in conditions like arteriovenous malformations and tumors.
What specialties typically use this device?
Interventional radiologists and vascular surgeons commonly use the Philips VeriFlex in their procedures.
What are the FDA-cleared indications?
The device is cleared for use in embolization procedures to block blood vessels in various clinical conditions.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.